Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 873.00M | $ 852.00M | $ 604.00M | $ 516.00M | $ 996.00M |
Total Assets | $ 15.99B | $ 15.78B | $ 15.37B | $ 15.68B | $ 16.82B |
Total Debt | $ 9.55B | $ 10.09B | $ 11.02B | $ 11.61B | $ 12.98B |
Net Debt | $ 8.68B | $ 9.24B | $ 10.42B | $ 11.10B | $ 11.98B |
Total Liabilities | $ 12.19B | $ 12.51B | $ 13.34B | $ 14.09B | $ 15.70B |
Stockholders Equity | $ 3.71B | $ 3.15B | $ 1.93B | $ 1.47B | $ 1.03B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |